Cargando…

Correction: Inactivation of TIF1γ Cooperates with Kras(G12D) to Induce Cystic Tumors of the Pancreas

Detalles Bibliográficos
Autores principales:	Vincent, David F., Yan, Kai-Ping, Treilleux, Isabelle, Gay, Fabien, Arfi, Vanessa, Kaniewski, Bastien, Marie, Julien C., Lepinasse, Florian, Martel, Sylvie, Goddard-Leon, Sophie, Iovanna, Juan L., Dubus, Pierre, Garcia, Stéphane, Puisieux, Alain, Rimokh, Ruth, Bardeesy, Nabeel, Scoazec, Jean-Yves, Losson, Régine, Bartholin, Laurent
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722421/ http://dx.doi.org/10.1371/annotation/7941c465-532f-4b42-b541-72d0810943b9

Ejemplares similares

Inactivation of TIF1γ Cooperates with Kras(G12D) to Induce Cystic Tumors of the Pancreas
por: Vincent, David F., et al.
Publicado: (2009)

Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRAS(G12D)-driven Pancreatic Tumorigenesis
por: Chuvin, Nicolas, et al.
Publicado: (2017)

Autophagy Induced during Pancreatitis Promotes KRAS-Dependent Transformation in the Pancreas
por: Iovanna, Juan L.
Publicado: (2016)

TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients
por: Kassem, Loay, et al.
Publicado: (2015)

Dynamic Regulation of Tgf-B Signaling by Tif1γ: A Computational Approach
por: Andrieux, Geoffroy, et al.
Publicado: (2012)

iNKT cell development is orchestrated by different branches of TGF-β signaling
por: Doisne, Jean-Marc, et al.
Publicado: (2009)

Generation of an Fsp1 (fibroblast‐specific protein 1)‐Flpo transgenic mouse strain
por: Cardot‐Ruffino, Victoire, et al.
Publicado: (2020)

Generation of a conditional Flpo/FRT mouse model expressing constitutively active TGFβ in fibroblasts
por: Cardot-Ruffino, Victoire, et al.
Publicado: (2020)

Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype
por: Grelier, G, et al.
Publicado: (2009)

Tracker ready for transport at TIF
por: Hoch, Michael
Publicado: (2007)

The CMS Tracker support tube in the TIF.
por: Michael Eppard
Publicado: (2005)

Transport of the Tracker from TIF to CMS
por: Hoch, Michael
Publicado: (2007)

The evolution of TIF: transoral incisionless fundoplication
por: Ihde, Glenn M.
Publicado: (2020)

The Roles of TIF1γ in Cancer
por: Yu, Chengpeng, et al.
Publicado: (2019)

Images of the CMS Tracker Integration Facility (TIF)
por: Eppard, M
Publicado: (2008)

Diseño de prototipo de rastro "TIF"
por: Altamirano Juárez, Rosa Laura
Publicado: (2009)

TIF1 Proteins in Genome Stability and Cancer
por: McAvera, Roisin M., et al.
Publicado: (2020)

1. TIF1-γ associated dermatomyositis
por: Waller, Rosemary, et al.
Publicado: (2019)

MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2
por: Yin, Hong, et al.
Publicado: (2007)

Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
por: Luo, Yongde, et al.
Publicado: (2021)

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

Oncogenic Kras-Mediated Cytokine CCL15 Regulates Pancreatic Cancer Cell Migration and Invasion through ROS
por: Messex, Justin K., et al.
Publicado: (2022)

Lysyl oxidase activity regulates oncogenic stress response and tumorigenesis
por: Wiel, C, et al.
Publicado: (2013)

Intraductal papillary mucinous neoplasms of the pancreas: Clinical association with KRAS
por: Chang, Xiao Yan, et al.
Publicado: (2018)

Clinical characteristics of patients with anti-TIF1-γ antibodies
por: Masiak, Anna, et al.
Publicado: (2016)

Expression of the MOZ-TIF2 oncoprotein in mice represses senescence
por: Largeot, Anne, et al.
Publicado: (2016)

Cten Is Targeted by Kras Signalling to Regulate Cell Motility in the Colon and Pancreas
por: Al-Ghamdi, Saleh, et al.
Publicado: (2011)

Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis
por: Satoh, Minoru, et al.
Publicado: (2012)

TIF-Seq2 disentangles overlapping isoforms in complex human transcriptomes
por: Wang, Jingwen, et al.
Publicado: (2020)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
por: Gutierrez, Daniel, et al.
Publicado: (2022)

KRAS mutation analysis in ductal carcinoma of the pancreas; prognostic implications in elderly patients
por: Oldani, Alberto, et al.
Publicado: (2013)

Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation()()
por: Drosos, Yiannis, et al.
Publicado: (2016)

STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines
por: Grant, Trevor J., et al.
Publicado: (2017)

Nuclear GSK-3β and Oncogenic KRas Lead to the Retention of Pancreatic Ductal Progenitor Cells Phenotypically Similar to Those Seen in IPMN
por: Ding, Li, et al.
Publicado: (2022)

Diagnóstico económico y financiero del rastro TIF de Tihuatlán, Ver./
por: Rodríguez Salas, María Inés
Publicado: (1997)

Role of TIF1α as a modulator of embryonic transcription in the mouse zygote
por: Torres-Padilla, Maria Elena, et al.
Publicado: (2006)

The Association between TIF1 Family Members and Cancer Stemness in Solid Tumors
por: Czerwinska, Patrycja, et al.
Publicado: (2021)

TIF-Reg: Point Cloud Registration with Transform-Invariant Features in SE(3)
por: Chen, Baifan, et al.
Publicado: (2021)

Tetrahedral Imidazolate Frameworks with Auxiliary Ligands (TIF-Ax): Synthetic Strategies and Applications
por: Hao, Tong, et al.
Publicado: (2023)

Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey
por: Park, Joon Tae, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_soj5muvog3nesmn51fjk84mtbv